Ursodiol Dosage Calculator for Dogs (Ursodeoxycholic Acid)

Ursodiol for Dogs – Hepatic + Biliary Support

Ursodiol (ursodeoxycholic acid) is a hydrophilic bile acid used for chronic hepatitis, cholestasis, biliary sludge, gallbladder mucocele, and cholesterol gallstones in dogs.

Standard Dose

10-15 mg/kg PO every 24 hours (or split q12h for tolerance)

Mucocele management may use 15-25 mg/kg.

Dose Reference Table

Mechanism

• Choleretic – increases bile flow
• Displaces toxic hydrophobic bile acids
• Anti-inflammatory
• Anti-apoptotic – protects hepatocytes
• Immunomodulatory – reduces MHC expression
• Gallstone dissolution (cholesterol-based)
• Mucocele management (early stable)

⚠ Give With Food

Improves absorption + reduces GI upset.

Common Combination: Ursodiol + Denamarin

Complementary mechanisms:

• Ursodiol – bile duct level (with food)
• Denamarin – hepatocyte level (empty stomach)

Timing: Denamarin morning empty stomach, Ursodiol with breakfast 1 hour later.

Gallbladder Mucocele

Besso Classification

• Type 1 – sludge with stellate pattern
• Type 2 – immobile sludge
• Type 3 – kiwi-like mucocele
• Type 4 – kiwi-like + wall thickening
• Type 5 – ruptured (emergency)

Predisposed Breeds

• Shetland Sheepdog (Sheltie)
• Cocker Spaniel
• Miniature Schnauzer

Predisposing Conditions

• Hyperadrenocorticism (Cushing’s)
• Hypothyroidism

Treatment

• Medical (ursodiol + low-fat diet + treat underlying) – Type 1-2 stable
• Surgical cholecystectomy – Type 3+ or symptomatic
• Monitor ultrasound every 3-6 months

Side Effects

Common

• Mild diarrhea (most common; BID split helps)
• Vomiting occasionally
• Decreased appetite

Rare

• Paradoxical hepatic enzyme elevation
• Pruritus
• Allergic reaction

Drug Interactions

AVOID separation needed

• Aluminum antacids – bind ursodiol (separate 2+ hours)
• Cholestyramine – binds bile acids
• Estrogen products – counteract
• Clofibrate – counteracts

Safe combinations

• Denamarin – standard complement
• Prednisone – chronic hepatitis combo
• Most other medications

Contraindications

• Biliary obstruction – surgery first
• Gallbladder rupture – emergency
• Pregnancy – caution

Monitoring

• Baseline bloodwork before starting
• 30-60 days recheck
• Every 3-6 months stable
• Ultrasound for mucocele every 3-6 months
• Expected: ALP reduction, bilirubin normalization

Frequently Asked Questions

How much ursodiol should I give my dog?

STANDARD DOSE: 10-15 mg/kg PO every 24 hours. May split BID (q12h) for tolerance. GALLBLADDER MUCOCELE may use higher dose 15-25 mg/kg. EXAMPLES: 1) 5 kg dog: 50-75 mg/day; 2) 10 kg: 100-150 mg/day; 3) 15 kg: 150-225 mg/day; 4) 20 kg: 200-300 mg/day; 5) 30 kg: 300-450 mg/day; 6) 40 kg: 400-600 mg/day. FORMULATIONS: 1) 300 mg capsules (Actigall brand, generic available) – most common; 2) 250 mg tablets; 3) COMPOUNDED LIQUID 25 mg/mL for small dogs/precise dosing; 4) Capsules cannot easily be split – compounded liquid better for small dogs. ADMINISTRATION: 1) GIVE WITH FOOD – improves absorption + reduces GI upset; 2) Split BID may improve tolerance + steady-state levels; 3) Capsules can sometimes be opened (vet guidance) and content mixed with food for very small dogs; 4) Compounded liquid for precise small dog dosing; 5) Same time daily for consistency. DURATION: 1) Long-term/lifelong for chronic hepatic disease; 2) Minimum 30-60 days trial; 3) Recheck bloodwork; 4) Continue if improvement; 5) Adjust dose based on response; 6) Don’t discontinue abruptly without vet guidance. COMBINATION TIMING with Denamarin: 1) Denamarin morning EMPTY STOMACH; 2) Wait 1 hour; 3) Ursodiol with breakfast; 4) Or evening alternative: ursodiol with dinner, Denamarin late evening 2+ hours after; 5) Daily consistency more important than exact timing. WORK WITH VETERINARIAN to determine correct dose for your dog’s condition + monitoring plan.

What is ursodiol used for in dogs?

Multiple HEPATIC + BILIARY indications. PRIMARY USES: 1. CHRONIC HEPATITIS – inflammation of liver tissue: a) Often combined with Denamarin + prednisone; b) Lifelong management; c) Reduces inflammation + supports bile flow; 2. CHOLESTASIS – impaired bile flow: a) Drug-induced (steroids, anticonvulsants); b) Infection-related; c) Idiopathic; d) Increases bile production; 3. BILIARY SLUDGE – thick bile in gallbladder: a) May progress to mucocele; b) Early intervention helpful; c) Monitor with ultrasound; 4. GALLBLADDER MUCOCELE – immobile bile/mucus accumulation: a) Medical management for early stable cases (Besso Type 1-2); b) Surgical removal for Type 3+ or symptomatic; c) Predisposed breeds: Sheltie, Cocker Spaniel, Mini Schnauzer; d) Hyperadrenocorticism + hypothyroidism predispose; e) Low-fat diet + treat underlying; 5. CHOLESTEROL GALLSTONES – small cholesterol-based: a) Gradual dissolution over months; b) Calcified pigment stones do NOT dissolve; c) Surgical removal if symptomatic; 6. COPPER STORAGE DISEASE – adjunct to D-penicillamine or zinc: a) Bedlington Terrier (most common); b) West Highland White Terrier; c) Doberman; d) Dalmatian; e) Skye Terrier; f) Lifelong management; 7. PORTOSYSTEMIC SHUNT – post-surgical adjunct: a) Congenital or acquired; b) Supports hepatic function during recovery; 8. CHOLANGITIS – bile duct inflammation: a) Lymphocytic-plasmacytic; b) Bacterial; c) Adjunctive treatment; 9. DUCTAL PLATE MALFORMATION – hereditary biliary abnormality. MECHANISM: 1) CHOLERETIC – increases bile flow; 2) Displaces toxic hydrophobic bile acids (chenodeoxycholic, lithocholic); 3) Anti-inflammatory; 4) Immunomodulatory; 5) Anti-apoptotic (protects hepatocytes); 6) Gallstone dissolution (cholesterol-based). EVIDENCE: 1) Standard veterinary practice for hepatic disease; 2) Studies support efficacy in chronic hepatitis; 3) Mucocele management evolving; 4) Combined with other treatments typically; 5) Generally well-tolerated long-term. WHO BENEFITS: 1) Dogs with chronic hepatitis; 2) Predisposed breeds for mucocele (Sheltie, Cocker, Schnauzer); 3) Dogs with biliary sludge; 4) Cholestatic patterns on bloodwork; 5) Cholesterol gallstone patients; 6) Copper storage breeds; 7) Post-portosystemic shunt surgery. WORK WITH VETERINARIAN for accurate diagnosis + treatment planning. Ultrasound often diagnostic for biliary issues. Biopsy may guide chronic hepatitis treatment.

Can I give ursodiol and Denamarin together?

YES – STANDARD complementary combination for chronic hepatic disease. Different mechanisms work synergistically. COMPLEMENTARY MECHANISMS: 1) URSODIOL acts at BILE DUCT level: a) Choleretic (increases bile flow); b) Displaces toxic bile acids; c) Anti-inflammatory at biliary tree; d) Protects hepatocytes via reduced bile acid toxicity; 2) DENAMARIN (SAMe + silybin) acts at HEPATOCYTE level: a) Replenishes glutathione (master antioxidant); b) Stabilizes hepatocyte membranes; c) Anti-fibrotic via silybin; d) Antioxidant; 3) TOGETHER = comprehensive hepatic support. ADMINISTRATION TIMING: 1) Denamarin requires EMPTY STOMACH (food reduces absorption 50-80%); 2) Ursodiol requires WITH FOOD (improves absorption + tolerability); 3) Different timing accommodates both; 4) OPTION A (most common): a) Morning – Denamarin empty stomach upon waking; b) Wait 1 hour; c) Breakfast + ursodiol; d) Evening – dinner; e) Optional second ursodiol with dinner; 5) OPTION B: a) Morning breakfast + ursodiol; b) Evening dinner; c) Late evening 2+ hours after dinner – Denamarin empty stomach; 6) Daily consistency more important than exact timing. PROVEN COMBINATION for: 1) Chronic hepatitis (both immune-mediated + idiopathic); 2) Cholestatic liver disease; 3) Copper storage disease (third with chelator); 4) Drug-induced hepatic injury; 5) Hepatic fibrosis; 6) Recovery from acute hepatic insult; 7) Senior dogs with declining hepatic function; 8) Drug-affected liver (chronic NSAIDs, phenobarbital, etc.). DOSING when combined: 1) Each at their standard dose; 2) Don’t need to reduce either; 3) Both lifelong typically; 4) Adjust based on response not interaction; 5) Independent dose adjustments. SAFETY: 1) Excellent combination safety; 2) Very few interactions; 3) Both well-tolerated; 4) Side effect profiles different; 5) Monitor bloodwork together; 6) Discontinue or adjust if issues with either. ADDITIONAL COMBO MEDICATIONS for chronic hepatitis: 1) PREDNISONE – immune-mediated chronic hepatitis; 0.5-2 mg/kg q24h tapering; 2) AZATHIOPRINE – immunosuppression adjunct; 3) MYCOPHENOLATE – second-line immunosuppression; 4) D-PENICILLAMINE – copper chelation; 5) ZINC ACETATE – copper management; 6) VITAMIN E – antioxidant 400-800 IU/day; 7) OMEGA-3 FATTY ACIDS – anti-inflammatory; 8) HEPATIC DIET (Hill’s l/d, Royal Canin Hepatic); 9) ANTIBIOTICS if bacterial component (metronidazole, amoxicillin); 10) MAROPITANT (Cerenia) for nausea/inappetence. MONITORING combined therapy: 1) Baseline bloodwork before starting both; 2) Recheck 30-60 days; 3) Every 3-6 months stable; 4) Bile acids (pre + post-prandial); 5) Albumin, glucose, cholesterol; 6) Ultrasound for hepatic + biliary architecture; 7) Possibly liver biopsy if etiology unclear. EXPECTED IMPROVEMENTS: 1) Liver enzymes (ALT, ALP, GGT) reduction 30-50%; 2) Bilirubin normalization if elevated; 3) Bile acids improvement; 4) Albumin maintained/improved; 5) Clinical signs improvement; 6) Energy + appetite better; 7) Coat improvement; 8) Weight stabilization. COST CONSIDERATIONS: 1) Both medications can be expensive; 2) Long-term commitment; 3) Generic ursodiol available; 4) Denamarin name-brand or generic SAMe + silybin; 5) Online pharmacies often cheaper; 6) Cost-benefit favorable for chronic disease management; 7) Manufacturer rebates seasonal. COMMUNICATE with VET: 1) Confirm both prescribed; 2) Discuss timing strategy; 3) Side effects monitoring; 4) Bloodwork schedule; 5) Adjust if needed; 6) Long-term plan; 7) Quality of life assessment.

What are ursodiol side effects in dogs?

Generally WELL-TOLERATED. Side effects uncommon and mostly mild. COMMON (5-10%): 1) MILD DIARRHEA – most common side effect; usually resolves with: a) Splitting dose BID; b) Dose reduction; c) Giving with food consistently; d) Often improves over 1-2 weeks; e) If persistent – vet evaluation; 2) Vomiting – occasional; usually transient; 3) DECREASED APPETITE – mild; usually improves; 4) Loose stool. UNCOMMON (1-5%): 1) Paradoxical hepatic enzyme elevation – rare; 2) Pruritus (itching) – mild; 3) Skin rash – rare; 4) Increased thirst slight. RARE: 1) Allergic reaction; 2) Severe GI upset; 3) Significant liver enzyme increase; 4) Hypersensitivity. SIDE EFFECT MANAGEMENT: 1) DIARRHEA: a) Split daily dose into BID; b) Reduce dose by 25% if persistent; c) Give with larger meal; d) Try with different food; e) Probiotics adjunct; f) If severe or persistent – vet eval; g) Usually resolves first 1-2 weeks; 2) VOMITING: a) Give with food consistently; b) Smaller more frequent doses; c) Reduce dose if persistent; d) Vet eval if not resolving; 3) DECREASED APPETITE: a) Often improves; b) Highly palatable foods; c) Hand-feeding initially; d) Maropitant (Cerenia) if severe; 4) PARADOXICAL ENZYMES: a) Continue at reduced dose; b) Recheck 30 days; c) Usually transient; d) Discontinue if marked + persistent. CONTRAINDICATIONS: 1) BILIARY OBSTRUCTION – critical contraindication; ursodiol increases bile production; CANNOT pass through obstructed system; surgical relief first; 2) GALLBLADDER RUPTURE – emergency; surgical, not medical; 3) Hypersensitivity (rare); 4) PREGNANCY caution – safety not established; benefit-risk discussion. DRUG INTERACTIONS: 1) ALUMINUM ANTACIDS – bind ursodiol; separate 2+ hours; 2) CHOLESTYRAMINE – binds bile acids; reduce ursodiol efficacy; avoid; 3) COLESTIPOL – similar; avoid; 4) ESTROGENS – may counteract ursodiol; 5) CLOFIBRATE – counteract; 6) CYCLOSPORINE – bidirectional interactions; monitor; 7) ORAL CONTRACEPTIVES (if applicable) – counteract; 8) DENAMARIN – standard complementary combination; 9) PREDNISONE – safe combination for hepatitis; 10) Most other medications – safe to combine. MONITORING: 1) BASELINE bloodwork before starting: a) CBC; b) Chemistry (ALT, ALP, GGT, total bilirubin, albumin, glucose, BUN); c) Bile acids (pre + post-prandial); d) Coagulation profile if severe liver disease; 2) RECHECK 30-60 days; 3) Every 3-6 months once stable; 4) If side effects develop – check earlier; 5) ULTRASOUND for biliary architecture; 6) Liver biopsy if etiology unclear (rarely needed). DRUG INTERACTIONS to ENSURE SAFETY: 1) Tell all veterinarians about ursodiol; 2) Disclose all medications + supplements; 3) Pharmacy double-check; 4) Don’t add new medications without vet check; 5) Special caution with hepatic-affecting drugs. WHEN TO CONTACT VET: 1) Persistent diarrhea or vomiting; 2) Decreased appetite over 24-48 hours; 3) Marked lethargy; 4) Jaundice (yellowing eyes/gums); 5) Increased thirst significantly; 6) Skin reactions; 7) Any new concerning sign; 8) Bloodwork abnormalities. EXCELLENT SAFETY PROFILE: 1) Used in dogs decades; 2) Well-studied; 3) Most dogs tolerate well long-term; 4) Cost-effective; 5) Few drug interactions; 6) Adjunct to other hepatic treatments; 7) Quality of life maintained; 8) Survival benefit in chronic hepatitis. CONSIDER STOPPING if: 1) Severe persistent side effects despite adjustment; 2) Allergic reaction; 3) Acute hepatic failure development; 4) Biliary obstruction develops; 5) Owner choice; 6) Disease cured (rare). Most dogs continue ursodiol lifelong for chronic conditions with excellent tolerability.

Related PuppaDogs Calculators

Continue building your dog’s personalised care plan with these related PuppaDogs calculators:

• Dog Pregnancy / Whelping Due-Date Calculator
• Puppy Weight Predictor (Adult Weight Calculator)
• Heatstroke Risk Calculator for Dogs
• Bloat (GDV) Risk Calculator for Dogs
• Dog Life Expectancy Calculator (Breed, Body Condition, Lifestyle)
• Spay/Neuter Timing Calculator for Dogs (Breed-Specific)

Related Articles & Guides

Read the in-depth PuppaDogs guides that explain the science and clinical context behind this calculator:

• Ursodiol For Dogs: Benefits, Dosage, Side Effects, and More

References & Further Reading

The dosing ranges and safety information on this page are drawn from the following veterinary references. Always defer to your own veterinarian and the manufacturer’s label for your specific product.

1. Plumb DC. Plumb’s Veterinary Drug Handbook – ursodiol.
2. Center SA. Hepatobiliary tract.
3. Webster CR, Cooper J. Therapeutic use of cytoprotective agents in canine liver disease.
4. Aguirre AL et al. Gallbladder disease in dogs.
5. Besso JG et al. Ultrasonographic appearance of gallbladder mucoceles.
6. Mehler SJ. Complications of biliary tract surgery.
7. Ettinger SJ, Feldman EC. Textbook of Veterinary Internal Medicine.
8. PuppaDogs. Denamarin Calculator, Liver Disease Pre-Test Calculator, Pancreatitis Calculator. puppadogs.com.

Suyash Dhoot